Melanoma

Front Cover
Demos Medical Publishing, Dec 17, 2012 - Medical - 408 pages

Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum.

With contributions from nationally recognized experts representing the fields of dermatology, dermatologic surgery, surgical oncology, dermatopathology, and medical oncology, Melanoma includes chapters on prevention, changes in melanoma staging, the evolving role of established surgical therapies, single-agent specific V600E mutant inhibitors, target therapy for patients without BRAF mutations, new treatments for metastatic melanoma-including ipilimumab and vemurafenib-and more.

 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Foreword
ix
Preface
xi
Contributors
xiii
Preventing Melanoma
391
Evolution of the Melanoma Staging System
405
Less Common Variants of Cutaneous Melanoma
421
Controversies in the Management of the Regional Node Basin in Cutaneous Melanoma
461
Adjuvant Therapy for Melanoma
471
RAF Kinase Inhibitor Therapy in Melanoma
485
Emerging Targets for Melanoma Therapy Besides BRAF
501
The New Frontier of TCell Antibodies A Paradigm Shift in ImmunoOncology
517
Adoptive Cell Transfer Immunotherapy for Patients With Metastatic Melanoma
531
Immunotherapies for Metastatic Melanoma
547
Updated Approach to the Patient With Metastatic Melanoma
583
Index
603
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information